Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models

Published:2020-01-21 Issue:2 Volume:130 Page:942-957
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Ruiz Santiago^ORCID,Zhao Haitian,Chandakkar Pallavi,Papoin Julien^ORCID,Choi Hyunwoo^ORCID,Nomura-Kitabayashi Aya,Patel Radhika,Gillen Matthew,Diao Li^ORCID,Chatterjee Prodyot K.,He Mingzhu,Al-Abed Yousef,Wang Ping^ORCID,Metz Christine N.^ORCID,Oh S. Paul^ORCID,Blanc Lionel^ORCID,Campagne Fabien^ORCID,Marambaud Philippe^ORCID

Funder

NIH/NHLBI

DOD/CDMRP

Leducq foundation

Feinstein Institutes for Medical Research fund

Barrow Neurological Foundation fund

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/127425/files/pdf

Reference67 articles.

1. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia

2. Hereditary haemorrhagic telangiectasia: Pathophysiology, diagnosis and treatment

3. Hereditary hemorrhagic telangiectasia: from molecular biology to patient care

4. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1

5. Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How I treat bleeding in hereditary hemorrhagic telangiectasia;Blood;2024-08-29

2. BMP10 accelerated spinal astrocytic activation in neuropathic pain via ALK2/smad1/5/8 signaling;Frontiers in Pharmacology;2024-08-12

3. A KLF2-BMPER-Smad1/5 checkpoint regulates high fluid shear stress-mediated artery remodeling;Nature Cardiovascular Research;2024-07-08

4. Defining the Role of Oral Pathway Inhibitors as Targeted Therapeutics in Arteriovenous Malformation Care;Biomedicines;2024-06-11

5. Hepatic manifestations of hereditary haemorrhagic telangiectasia;Liver International;2024-06-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3